Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Expert Rev Vaccines. 2015 Dec 2;15(4):509–517. doi: 10.1586/14760584.2016.1115727

Table 4.

Frequency of detectable viremia for individual components of LATV in flavivirus-naive subjects

% subjects with vaccine viremia
Admixture N1 Any virus rDEN1Δ30 rDEN2/4Δ30 rDEN3Δ30/31 rDEN4Δ30
TV003 60 75.0 25.0 6.72 38.3 30.0
TV005 60 77.0 28.3 21.72 41.7 30.0
1

Data from two different studies were combined [17,21]

2

unadjusted P = 0.034; adjusted for multiple comparison P = 0.136